“Living” RWD for Enterprise Evidence Generation
Given the recent rapid pace of innovation, expansion, and adoption in the move to value-based medicine; real-world data can no longer be a series of static, one-time purchases. Rather, the new paradigm of insight and real-world evidence (RWE) generation is lifelong and enterprise-level and requires a living dataset that can grow and evolve with the needs of researchers and the patients they serve.
Join Warren Whyte, PhD, Vice President of Scientific Partnerships and Customer Success at ConcertAI, for a live webinar on how “living” datasets work and how such advanced oncology RWD can accelerate an enterprise-level approach to RWE.
Racial Equity in Study Design: Increasing Minority Participation in Trials
Under-representation of minority patients in clinical trials continues to be an ongoing problem. Traditional study criteria and methods don’t capture the different requirements needed to make trials more equitable and representative.
Please join Dr. Jeremy Miller, PhD, and senior director of technical solutions at ConcertAI, for a short webinar on how advanced RWD and AI technologies are helping find more patients from diverse racial backgrounds who are eligible to enroll in oncology trials.